These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11918278)

  • 1. Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation.
    Sözmen EY; Sözmen B; Girgin FK; Delen Y; Azarsiz E; Erdener D; Ersöz B
    Clin Exp Med; 2001 Dec; 1(4):195-9. PubMed ID: 11918278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
    Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW
    Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
    Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M
    Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cortical thickness and PON1 activity both decrease in chronic renal failure.
    Ak G; Ozgönül M; Sözmen EY; Aslan SL; Sözmen B
    J Nephrol; 2002; 15(2):144-9. PubMed ID: 12018630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
    Akçay YD; Sagin FG; Sendağ F; Oztekin K; Sozmen EY
    Maturitas; 2006 Feb; 53(3):325-32. PubMed ID: 16023312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation.
    Sezer ED; Sozmen EY; Nart D; Onat T
    Vasc Health Risk Manag; 2011; 7():333-43. PubMed ID: 21731885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein.
    Graham A; Hassall DG; Rafique S; Owen JS
    Atherosclerosis; 1997 Dec; 135(2):193-204. PubMed ID: 9430369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase gene polymorphisms and coronary reactivity in young healthy men.
    Malin R; Knuuti J; Janatuinen T; Laaksonen R; Vesalainen R; Nuutila P; Jokela H; Laakso J; Jaakkola O; Solakivi T; Lehtimäki T
    J Mol Med (Berl); 2001 Aug; 79(8):449-58. PubMed ID: 11511975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
    Sözmen EY; Sözmen B; Delen Y; Onat T
    Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Paraoxonase 1 Activity and Oxidative/Antioxidative Stress Markers in Patients with Acute Cerebral Infarction.
    Zhu H; Zhao T; Liu J
    Clin Lab; 2018 Jun; 64(6):1049-1053. PubMed ID: 29945323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control.
    Sözmen B; Delen Y; Girgin FK; Sözmen EY
    Clin Biochem; 1999 Aug; 32(6):423-7. PubMed ID: 10667477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
    Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
    Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R/R genotype of human paraoxonase (PON1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects.
    Kuremoto K; Watanabe Y; Ohmura H; Shimada K; Mokuno H; Daida H
    J Atheroscler Thromb; 2003; 10(2):85-92. PubMed ID: 12740482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
    Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
    J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the human paraoxonase polymorphism (PON1 192) on the carotid-wall thickening in a healthy population.
    Dessì M; Gnasso A; Motti C; Pujia A; Irace C; Casciani S; Staffa F; Federici G; Cortese C
    Coron Artery Dis; 1999 Dec; 10(8):595-9. PubMed ID: 10599538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.